|
Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Business Market Research
Energy Market Research
Financial Market Research
Pharmaceutical Market Research
Telecoms Market Research
|
Home > Market Research > Medical Devices > Independence Technology Medical Device Company Intelligence Report
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
Johnson & Johnson’s Independence Technology subsidiary, based in Warren, New Jersey, USA, was established in 1999 to develop and market an advanced gyro-balanced, battery-operated mobility system. The device, known as the Independence iBOT Mobility System, was invented by Dean Kamen, founder of DEKA Research & Development. J&J has been in partnership with this company since 1995 for the development of the iBOT, a wheelchair which can be operated on two or four wheels, stabilising the user by automatically adjusting and balancing itself using a combination of electronic, sensor and software components.
The system’s features include the ability to allow a seated user to move and interact with others at eye-level while the wheelchair is balanced on two wheels. Its rotating four-wheel base is designed to allow the user to climb stairs and traverse uneven terrain while keeping them level and balanced. The company’s latest system, the iBOT 4000 Mobility System, received FDA approval in March 2005.
Independence Technology’s current focus is to receive reimbursement approval in the US for the system. In September 2005, it submitted a Request for a National Coverage Determination (NCD) to the Centers for Medicare and Medicaid Services (CMS). However, in July 2006, the CMS determined it would class iBOT 4000 as a standard wheelchair. Independence Technology is in the process of challenging this decision. The company is also awaiting the final determination on its assigned pay-out level.
Top of Page
Table of Contents
Overview, Products, Research & Development, International Activities, Key Corporate Events, Mergers & Acquisitions
For full details, please email keithw@cmsinfo.com
Top of Page
Buy now!
Top of Page
|
|
